Host-Microbiome Associations in Saliva Predict COVID-19 Severity
H. Alqaderi, K. Altabtbaei, J. L. Espinoza, S. Bin-Hasan, M. Alghounaim, A. Alawady, A. Altabtabae, S. AlJamaan, S. Devarajan, T. AlShammari, M. B. Eid, M. Matsuoka, H. Jang, C. Dupont, M. Freire
Abstract
Established evidence indicates that oral microbiota plays a crucial role in modulating host immune responses to viral infection. Following Severe Acute Respiratory Syndrome Coronavirus 2 - SARS-CoV-2 - there are coordinated microbiome and inflammatory responses within the mucosal and systemic compartments that are unknown. The specific roles that the oral microbiota and inflammatory cytokines play in the pathogenesis of COVID-19 are yet to be explored. We evaluated the relationships between the salivary microbiome and host parameters in different groups of COVID-19 severity based on their Oxygen requirement. Saliva and blood samples (n = 80) were collected from COVID-19 and from non-infected individuals. We characterized the oral microbiomes using 16S ribosomal RNA gene sequencing and evaluated saliva and serum cytokines using Luminex multiplex analysis. Alpha diversity of the salivary microbial community was negatively associated with COVID-19 severity. Integrated cytokine evaluations of saliva and serum showed that the oral host response was distinct from the systemic response. The hierarchical classification of COVID-19 status and respiratory severity using multiple modalities separately (i.e., microbiome, salivary cytokines, and systemic cytokines) and simultaneously (i.e., multi-modal perturbation analyses) revealed that the microbiome perturbation analysis was the most informative for predicting COVID-19 status and severity, followed by the multi-modal. Our findings suggest that oral microbiome and salivary cytokines may be predictive of COVID-19 status and severity, whereas atypical local mucosal immune suppression and systemic hyperinflammation provide new cues to understand the pathogenesis in immunologically naive populations. Significance StatementThe oral mucosa is one of the first sites encountered by bacterial and viral infections, including SARS-CoV-2. It consists of a primary barrier occupied by a commensal oral microbiome. The primary function of this barrier is to modulate immunity and provide protection against invading infection. The occupying commensal microbiome is an essential component that influences the immune systems function and homeostasis. The present study showed that the host oral immune response performs unique functions in response to SARS-CoV-2 when compared to systemic responses during the acute phase. We also demonstrated that there is a link between oral microbiome diversity and COVID-19 severity. Additionally, the salivary microbiome was predictive of not only disease status but also severity.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity
- Profiling of oral microbiota and cytokines in COVID-19 patients
V. Iebba, N. Zanotta, … M. Comar·bioRxiv·Dec 13, 2020
- Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 regions sequences
J. Torres·bioRxiv·Oct 20, 2022
- Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis
Korina Yun-Fan Lu, Hend E. Alqaderi, … Khaled Altabtbaei·PLoS ONEPeer-reviewed·Jul 25, 2024
- The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19
B. Martin-Castano, P. Diez-Echave, … J. Galvez·eLifePeer-reviewed·Feb 18, 2025
- SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized COVID-19 patients
C. M. Basting, R. Langat, … N. R. Klatt·bioRxiv·Dec 7, 2023